Once - daily amoxicillin versus twice - daily penicillin V <font color="blue">in_1</font> <font color="blue">group_1</font> <font color="blue">A_1</font> <font color="blue">beta_2</font> <font color="blue">-_2</font> <font color="blue">haemolytic_2</font> <font color="blue">streptococcal_2</font> <font color="blue">pharyngitis_2</font> <font color="blue">._2</font> <font color="blue">
<br>
<br>_1</font> BACKGROUND <font color="blue">Rheumatic_1</font> <font color="blue">fever_1</font> is a preventable chronic disease preceded by <font color="blue">group_3</font> <font color="blue">A_3</font> <font color="blue">beta_3</font> <font color="blue">-_3</font> <font color="blue">haemolytic_3</font> <font color="blue">streptococcal_3</font> <font color="blue">(_3</font> <font color="blue">GABHS_3</font> <font color="blue">)_3</font> <font color="blue">pharyngitis_2</font> <font color="blue">._2</font> <font color="blue">
<br>_2</font> OBJECTIVE To test the non - inferiority of once - daily ( QD ) oral amoxicillin to the recommended twice - daily ( BID ) oral penicillin V in GABHS pharyngitis . 
<br> METHODS <font color="blue">This_1</font> <font color="blue">was_1</font> <font color="blue">a_1</font> <font color="blue">randomised_1</font> <font color="blue">non_1</font> <font color="blue">-_1</font> <font color="blue">inferiority_1</font> <font color="blue">trial_1</font> <font color="blue">carried_1</font> <font color="blue">out_1</font> <font color="blue">in_1</font> <font color="blue">a_1</font> <font color="blue">school_3</font> <font color="blue">-_3</font> <font color="blue">based_3</font> <font color="blue">clinic_3</font> <font color="blue">in_3</font> <font color="blue">New_4</font> <font color="blue">Zealand_4</font> <font color="blue">._4</font> <font color="blue">Children_5</font> <font color="blue">presenting_5</font> <font color="blue">with_5</font> <font color="blue">GABHS_5</font> <font color="blue">pharyngitis_5</font> were randomised to oral amoxicillin 1500 mg QD ( or 750 mg if bodyweight was < or=30 kg ) or to oral penicillin V 500 mg BID ( or 250 mg if bodyweight was < or=20 kg ) for 10 days . Observed medication and weekend diary cards were used to monitor adherence . 
<br> OUTCOME Eradication of GABHS , determined with follow - up throat cultures on days 3 - 6 , 12 - 16 and 26 - 36 . GABHS isolates were serotyped to distinguish bacteriological treatment failures ( and relapses ) from new acquisitions . Non - inferiority was defined as an upper 95% confidence limit ( CL ) for the difference in success of eradication in the amoxicillin and penicillin V treatment groups of < or=10% . 
<br> RESULTS <font color="blue">353_5</font> <font color="blue">children_5</font> <font color="blue">with_5</font> <font color="blue">positive_5</font> <font color="blue">throat_5</font> <font color="blue">swabs_5</font> <font color="blue">for_4</font> <font color="blue">GABHS_4</font> <font color="blue">were_2</font> <font color="blue">randomised_2</font> to amoxicillin ( n = 177 ) or penicillin V ( n = 176 ) . The upper 95% CL for the differences in positive cultures between the antibiotics was 4.9% at days 3 - 6 , 6.5% at days 12 - 16 and 8.5% at days 26 - 36 . Treatment failures ( including relapses ) occurred at each visit in 5.8% , 12.7% and 10.7% of amoxicillin recipients and 6.2% , 11.9% and 11.3% of penicillin V recipients , respectively . <font color="blue">No_1</font> <font color="blue">significant_1</font> <font color="blue">differences_1</font> <font color="blue">in_1</font> <font color="blue">resolution_1</font> <font color="blue">of_1</font> <font color="blue">symptoms_1</font> <font color="blue">were_1</font> <font color="blue">noted_1</font> <font color="blue">between_1</font> <font color="blue">treatment_1</font> <font color="blue">groups_1</font> <font color="blue">._1</font> One case of unsubstantiated acute rheumatic fever occurred after 7 days of amoxicillin . 
<br> CONCLUSION In this adequately powered study , once - daily oral amoxicillin is not inferior to twice - daily penicillin V for the treatment and eradication of <font color="blue">GABHS_2</font> <font color="blue">in_3</font> <font color="blue">children_5</font> <font color="blue">with_5</font> <font color="blue">pharyngitis_5</font> <font color="blue">._5</font> <font color="blue">
<br>
<br>_1</font>